New Insights on Maximizing Regulatory Impact from Consortium-Based Projects A recent article discusses how global consortiums can enhance regulatory influences on drug development, emphasizing strategic collaboration and early engagement with regulatory bodies.

New Insights on Maximizing Regulatory Impact from Consortium-Based Projects #USA #Tucson #Critical_Path_Institute #Innovative_Health_Initiative #Regulatory_Science

Advancing Drug Development: Insights from Recent C-Path Research in Regulatory Practices C-Path and IHI unveil a new paper highlighting how consortium-based projects can overcome regulatory obstacles in drug development. This could reshape patient care significantly.

Advancing Drug Development: Insights from Recent C-Path Research in Regulatory Practices #Brussels #Belgium #Critical_Path_Institute #Innovative_Health_Initiative #Regulatory_Science